November 3, 2006

Brigham Young U. Sues Pfizer for Fraud

By ERIN STROUT

Brigham Young University and one of its professors have accused Pfizer Inc. of fraud and misappropriation of trade secrets, among other things, in a lawsuit filed in the U.S. District Court in Salt Lake City. The complaint claims that the institution has lost at least $1-billion in profits from sales of the company's popular painkiller, Celebrex.

Celebrex belongs to a class of nonsteroidal anti-inflammatory drugs known as Cox-2 inhibitors, or "super aspirin."

According to the

Digital or Print Subscription

Web Pass

Already have an account? Log In Now.